Clinical Trial Update: Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of obatoclax in previously untreated acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Obatoclax (obatoclax mesylate)

Snippet

Sponsor: Gemin X | Conditions: AML | Phase 2 | Status: COMPLETED